Search
for
Sort by
Research 871–900 of 1000+
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Plasmacytoid dendritic cells in alopecia areata: missing link?
- Mind the Gap: Sex Bias in Basic Skin Research
- Congenital triangular alopecia: A close mimicker of alopecia areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Autoimmune gastritis and parietal cell reactivity in two children with abnormal intestinal permeability
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing
- The role of vitamin D in alopecia areata
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- 217 The adenosine-generating ecto-enzyme CD73 regulates human hair growth
- Medications
- Cutaneous Lupus Erythematosus
- Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning
- Pathobiology of chemotherapy-induced hair loss
- Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Probiotic Bacteria Induce a ‘Glow of Health’
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- THE PATHOGENESIS OF ALOPECIA AREATA
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- What causes hidradenitis suppurativa ?—15 years after
- Pathways to inflammation: acne pathophysiology
- Red ginseng monograph
- The Role of Micronutrients in Alopecia Areata: A Review
- Graft-versus-host disease
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study